Marlio Charles Mosseri, 10% Owner at Nuvectis Pharma, Inc. (NVCT), bought 47,029 shares at $8.64 ($405K) on 2025-05-06, disclosed to the SEC on 2025-05-09.
Open-market purchase of $405k NVCT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.40 | 2,340 | $20K | 4.9% |
| 2 | $8.64 | 10,104 | $87K | 21.5% |
| 3 | $8.64 | 10,104 | $87K | 21.5% |
| 4 | $8.40 | 2,703 | $23K | 5.6% |
| 5 | $8.64 | 9,614 | $83K | 20.5% |
| 6 | $8.64 | 9,614 |
| $83K |
| 20.5% |
| 7 | $8.65 | 50 | $433 | 0.1% |
| 8 | $8.65 | 100 | $865 | 0.2% |
| 9 | $8.65 | 2,400 | $21K | 5.1% |
| Total | $8.61 avg | 47,029 | $405K | 100% |
| Filing → |
| NVCT | BUY | 2025-06-24 | $45K | — | Filing → |
| NVCT | BUY | 2025-06-20 | $495K | — | Filing → |
| NVCT | BUY | 2025-05-13 | $343K | — | Filing → |